We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRGA
701
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $828K | 0.01% |
4,593
+251
| +6% | +$36.3K |
|
702
VYNE Therapeutics
VYNE
$19.1M
| $823K | 0.01% |
29
+2
| +7% | +$48K |
|
703
Hawaiian Electric Industries
HE
$2.28B
| $820K | 0.01% |
20,120
+3,000
| +18% | +$114K |
|
704
CEVA Inc
CEVA
$980M
| $812K | 0.01% |
+30,126
| New | +$818K |
|
705
Marten Transport
MRTN
$1.26B
| $803K | 0.01% |
67,529
-2,850
| -4% | -$34.8K |
|
|
ALEX
706
DELISTED
Alexander & Baldwin
ALEX
| $800K | 0.01% |
31,441
-7,290
| -19% | -$167K |
|
707
Amplify Energy
AMPY
$155M
| $796K | 0.01% |
81,491
-2,060
| -2% | -$19.1K |
|
708
Merck
MRK
$323B
| $790K | 0.01% |
9,956
| – | – |
|
|
IMGN
709
DELISTED
Immunogen Inc
IMGN
| $784K | 0.01% |
289,140
+735
| +0.3% | +$3.18K |
|
710
Materion
MTRN
$5.03B
| $783K | 0.01% |
13,729
-56,735
| -81% | -$2.95M |
|
711
Selective Insurance
SIGI
$5.53B
| $783K | 0.01% |
12,368
+400
| +3% | +$25.2K |
|
|
EE
712
DELISTED
El Paso Electric Company
EE
| $764K | 0.01% |
+12,990
| New | +$701K |
|
713
Comtech Telecommunications
CMTL
$54.5M
| $762K | 0.01% |
32,805
-7,888
| -19% | -$195K |
|
714
CytomX Therapeutics
CTMX
$708M
| $761K | 0.01% |
70,801
+39,500
| +126% | +$584K |
|
715
HNI Corp
HNI
$3.09B
| $760K | 0.01% |
20,940
+9,520
| +83% | +$366K |
|
|
TNAV
716
DELISTED
Telenav Inc.
TNAV
| $758K | 0.01% |
124,952
+36,500
| +41% | +$192K |
|
|
PSB
717
DELISTED
PS Business Parks, Inc.
PSB
| $754K | 0.01% |
4,810
+2,300
| +92% | +$335K |
|
718
Markel Group
MKL
$25.2B
| $751K | 0.01% |
754
+473
| +168% | +$480K |
|
719
Walmart Inc
WMT
$889B
| $741K | 0.01% |
+22,800
| New | +$739K |
|
720
First Merchants
FRME
$2.69B
| $740K | 0.01% |
20,072
| – | – |
|
721
Heritage Financial
HFWA
$1.22B
| $739K | 0.01% |
24,522
-10,630
| -30% | -$333K |
|
722
Greif
GEF
$4.56B
| $722K | 0.01% |
+17,510
| New | +$699K |
|
723
W&T Offshore
WTI
$492M
| $722K | 0.01% |
104,700
-25,800
| -20% | -$140K |
|
|
EGIO
724
DELISTED
Edgio, Inc. Common Stock
EGIO
| $722K | 0.01% |
5,591
+3,373
| +152% | +$392K |
|
|
ELGX
725
DELISTED
Endologix Inc
ELGX
| $722K | 0.01% |
109,203
+44,548
| +69% | +$294K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.